• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Becton Dickinson (NY: BDX )

    237.59 +0.25 (+0.11%)
    Streaming Delayed Price Updated: 12:38 PM EDT, Jul 25, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 764,216
    Open 237.34
    Bid (Size) 237.43 (4)
    Ask (Size) 237.75 (4)
    Prev. Close 237.34
    Today's Range 237.00 - 241.60
    52wk Range 218.75 - 286.46
    Shares Outstanding 287,190,180
    Dividend Yield 1.53%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Insulin Device Maker Embecta Weighs Sale After 70% Share Decline Following Becton Dickinson Spin-Off
    Embecta is exploring a potential sale after a nearly 70% drop in share price since its spin-off from Becton Dickinson. The company's U.S. business has struggled with the rise of GLP-1 drugs and... 
    Via Benzinga
    Looking Into Becton Dickinson's Recent Short Interest
    Via Benzinga

    Performance

    YTD
    -3.19%
    -3.19%
    1 Month
    +0.71%
    +0.71%
    3 Month
    +1.61%
    +1.61%
    6 Month
    +1.29%
    +1.29%
    1 Year
    -16.14%
    -16.14%

    More News

    Read More
    3 Healthcare Stocks to Buy Now to Profit From Aging Population Trends
    Via InvestorPlace
    Topics Retirement
    Exposures Pension
    UnitedHealth, Edwards Lifesciences, First Citizens Bank And More: CNBC's 'Final Trades'
    Via Benzinga
    Boing! 7 Undervalued Stocks That Could Surprise the Skeptics.
    Via InvestorPlace
    Peering Into Becton Dickinson's Recent Short Interest
    Via Benzinga
    Looking Into Becton Dickinson's Recent Short Interest
    Via Benzinga
    Peering Into Becton Dickinson's Recent Short Interest
    Via Benzinga
    Stock Market Revs To Highs On Nvidia, CrowdStrike, Yields: Weekly Review
    Via Investor's Business Daily
    Topics Stocks
    Exposures US Equities
    BD Bolsters Portfolio With $4.2B Cash Deal For Edwards Lifesciences' Critical Care Group: Details
    Via Benzinga
    Edwards Lifesciences Stock Nears Breakout On A Surprise $4.2 Billion Deal
    Via Investor's Business Daily
    Trade Winds Turning: 3 Stocks Poised to Gain from Biden’s China Tariffs
    Via InvestorPlace
    Topics World Trade
    Exposures Tariff
    Biden's New Tariffs On Chinese Imports Are A 'Clear Giveaway' To These Two Tesla Rivals, Jim Cramer Says: 'I Like This Policy'
    Via Benzinga
    Topics World Trade
    Exposures Tariff
    MarketBeat Week in Review – 4/29 - 5/3
    Via MarketBeat
    Topics Economy Stocks
    Exposures Interest Rates US Equities
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    Becton & Dickinson 'Is Well On Its Way To Achieving 2025 Commitments,' Analyst Optimistic On Outlook
    Via Benzinga
    BDX Stock Earnings: Becton, Dickinson Beats EPS, Beats Revenue for Q2 2024
    Via InvestorPlace
    Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
    Via MarketBeat
    How Much Will $10k Invested in These Dividend Aristocrats Grow to by 2025?
    Via InvestorPlace
    Rich Returns at a Discount: 3 Dividend Aristocrats Trading at 52-Week Lows
    Via InvestorPlace
    AngioDynamics Resolves Decade-Long Patent Litigation With Becton, Dickinson In Settlement Agreement
    Via Benzinga
    Topics Intellectual Property
    Exposures Intellectual Property
    Should You Buy Solventum (SOLV) Stock After the 3M Spinoff?
    Via InvestorPlace
    Jim Cramer Says Don't Sell This Beauty Brand, Believes KKR And Blackstone 'Can Make More Money'
    Via Benzinga
    Becton, Dickinson And Co. Dividend Stock Analysis
    Via Talk Markets
    FDA Probe On China-Made Syringes: Becton Dickinson Boosts US Syringe Output Following Concerns
    Via Benzinga
    Exposures Product Safety
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.